agerelatedmaculardegeneration

What is age-related macular degeneration?


Macular degeneration, or age-related macular degeneration (AMD) is a leading cause of vision loss in Americans 60 and older. It is a disease that destroys your sharp, central vision. You need central vision to see objects clearly and to do tasks such as reading and driving. AMD affects the macula, the part of the eye that allows you to see fine detail. It does not hurt, but it causes cells in the macula to die. In some cases, AMD advances so slowly that people notice little change in their vision. In others, the disease progresses faster and may lead to a loss of vision in both eyes. Regular comprehensive eye exams can detect macular degeneration before the disease causes vision loss. Treatment can slow vision loss. It does not restore vision.

Read more on www.nlm.nih.gov
Search for any health
topic on HealthMash:

Explore and Discover

Alternative Medicine
» ginkgo
» copper
» lutein

age-related macular degeneration information from trusted sources:

Macular Degeneration

The diagnosis of macular degeneration is becoming increasingly more common due to patient awareness, physician access, groundbreaking improvements in treatment, and the relentless graying of the population exponentially increases the percentage of the population at risk for this condition. Thus, macular degeneration is a formidable challenge to patients, their doctors, and our society as the costs for delivering state-of-the-art care increase.

Lucentis

Lucentis is used to treat neovascular (wet) age-related macular degeneration (AMD). Wet AMD causes central vision loss, which is the center area of what you see.

Read more on www.pdrhealth.com

Lucentis

LUCENTIS is indicated for the treatment of patients with neovascular (wet) age‑related macular degeneration.

Read more on www.druglib.com

Facts About Age-Related Macular Degeneration [NEI Health Information]

National Eye Institute's publication for people who are at higher risk for Age-Related Macular Degeneration. Encourages regular eye exams through dilated ...

Read more on www.nei.nih.gov

Macular degeneration - Wikipedia, the free encyclopedia

Age related macular degeneration is a medical condition which usually affects older adults that results in a loss of vision in the center of the visual ...

Read more on en.wikipedia.org

Age-Related Macular Degeneration: A Complete Guide

Oct 11, 2010 ... Age-related macular degeneration may not mean blindness; learn what you need to know about AMD types, symptoms, treatments and prevention.

Read more on www.allaboutvision.com

Age-Related Macular Degeneration (AMD) Causes, Symptoms, Treatment ...

Mar 19, 2011 ... Age-related macular degeneration (AMD) is a disease associated with ... Suggested Reading on Macular Degeneration (Age-Related Type) by Our ...

Read more on www.medicinenet.com

Macular Degeneration Partnership

The Macular Degeneration Partnership empowers people with Age-Related Macular Degeneration (AMD) by providing up-to-date, accurate information and ...

Read more on www.amd.org

There is Hope and Help for People Living with AMD – AMD Alliance

Age Related Macular Degeneration – or AMD – is an eye disease that causes loss of ... February 6, 2011|Age-Related Macular Degeneration: Key Mechanism in » ...

Read more on www.amdalliance.org

Age-Related Macular Degeneration | American Optometric Association

Macular degeneration is the leading cause of blindness in America. It results from changes to the macula, a portion of the retina that is responsible for ...

Read more on www.aoa.org

Contents

Macular Degeneration
Macular degeneration is an eye disorder that damages the center of the retina, which is called the macula. This makes it difficult to see fine details.

Read more on www.nlm.nih.gov
AMD
Macular degeneration is a painless eye condition that causes you gradually to lose your central vision (the ability to see what is directly in front of you). You use your central vision during activities such as reading, writing and driving.

Read more on www.nhs.uk
Macular degeneration, dry
Age-related macular degeneration is a chronic eye disease marked by deterioration of tissue in the part of your eye that's responsible for central vision. The deterioration occurs in the macula (MAK-u-luh), which is in the center of the retina the layer of tissue on the inside back wall of your eyeball.

Read more on www.mayoclinic.com
Macular degeneration, wet
Age-related macular degeneration is a chronic eye disease in which the part of your eye responsible for central vision your macula (MAK-u-luh) gradually deteriorates, causing blurred central vision or a blind spot in the center of your visual field. Macular degeneration tends to affect adults age 50 and older.

Read more on www.mayoclinic.com
Pegaptanib Injection
Pegaptanib injection is used to treat wet age-related macular degeneration (AMD, an ongoing disease of the eye that causes loss of the ability to see straight ahead and may make it more difficult to read, drive, or perform other daily activities). Pegaptanib injection is in a class of medications called vascular endothelial growth factor (VEGF) antagonists. It works by blocking abnormal blood vessel growth and leakage in the eye(s) that may cause vision loss in people with wet AMD.

Read more on www.nlm.nih.gov
Ranibizumab Injection
Ranibizumab is used to treat wet age-related macular degeneration (AMD, an ongoing disease of the eye that causes loss of the ability to see straight ahead and may make it more difficult to read, drive, or perform other daily activities). Ranibizumab is in a class of medications called vascular endothelial growth factor A (VEGF-A) antagonists. It works by blocking abnormal blood vessel growth and leakage in the eye(s) that may cause vision loss in people with wet AMD.

Read more on www.nlm.nih.gov
Macugen
Pegaptanib is used to treat neovascular (wet) age-related macular degeneration (AMD). AMD is a disorder of the retina of the eye that causes blurring of vision or blindness .

Read more on www.mayoclinic.com
Lucentis
Ranibizumab is used to treat neovascular (wet) age-related macular degeneration (AMD). AMD is a disorder of the retina of the eye that causes blurring of vision or blindness .

Read more on www.mayoclinic.com
Standard ophthalmic exam
Abnormal results may be due to:Age-related macular degeneration (ARMD), Astigmatism , Blocked tear duct , Cataracts , Color blindness, Corneal abrasion (or dystrophy), Corneal ulcers and infections , Damaged nerves or blood vessels in the eye, Diabetes-related nerve damage in the eye (diabetic retinopathy), Glaucoma, Hyperopia , Lazy eye (amblyopia), Myopia , Presbyopia , Strabismus , Trauma

Read more on www.nlm.nih.gov
Visual impairment
Evans JR, Antioxidant vitamin and mineral supplements for slowing the progression of age-related macular degeneration. Cochrane Database of Systematic Reviews 2006, Issue 2

Read more on www.nhs.uk
Verteporfin injection
Verteporfin injection is used in combination with photodynamic therapy (PDT, treatment with a laser light) to treat abnormal growth of leaky blood vessels in the eye caused by wet age-related macular degeneration (AMD, an ongoing disease of the eye that causes loss of the ability to see straight ahead and may make it more difficult to read, drive, or perform other daily activities), pathologic myopia (a serious form of nearsightedness that worsens with time), or histoplasmosis (a fungal infection) of the eye. Verteporfin is in a class of medications called photosensitizing agents. When verteporfin is activated by light, it closes up the leaking blood vessels.

Read more on www.nlm.nih.gov